Table 1. Summary table of studies reporting carriage of Streptococcus pneumoniae.
Reference | Study period | Country | Sample size | Prevalence | Age group | Prevalence of carriage, % (95% CI) | |
Low income countries | |||||||
Healthy population | |||||||
[65] | Saha et al. 2003 | 1999–2000 | Bangladesh | 2839 children | Point | Total | 46 |
[49] | Granat et al. 2007 | 2000–2001 | Bangladesh | 98 families with 99 new-borns | Average | 4–12 months | 49.3 |
1–4 years | 50.9 | ||||||
5–9 years | 41.5 | ||||||
10–18 years | 32.4 | ||||||
Mothers | 7.3 | ||||||
Other adults | 8.2 | ||||||
[116] | Coles et al. 2011 | 2005–2007 | Bangladesh | 225 children | Point | 12 weeks | 72.9 |
[42] | Cheung et al. 2009 | 2003 and 2003–2004 | The Gambia | 2342 children and 675 of their younger siblings | Point and average | Median age: 12 months. Median age siblings: 3 | 86.2a |
[53] | Roca et al. 2011 | 2003–2008 | The Gambia | 2094 individuals pre-vaccination | Point | 2–<5 years | 93.4a |
5–<15 years | 86.3 | ||||||
≥15 years | 60.6 | ||||||
[43] | Kwambana et al. 2011 | NR | The Gambia | 30 infants | Average | 0–12 months | 78 (76–83) |
[54] | Hill et al. 2010 | NR | The Gambia | 158 individuals | Period | Children | 97 (over study period) |
Period | Adults | 85 (over study period) | |||||
[50] | Hill et al. 2008 | NR | The Gambia | 236 infants | Period | 0–11 months | 20–90 (100 over study period) |
[57] | Hill et al. 2006 | NR | The Gambia | 2972 individuals | Point | Median age: 15 years | 72 |
[39] | Lloyd-Evans et al. 1996 | 1989–1991 | The Gambia | 113 children | Point | <5 years | 76.1 |
[55] | Abdullahi et al. 2008 | 2004 | Kenya | 450 individuals | Average | 0–4 years | 57 |
5–9 years | 41 (32–51) | ||||||
10–85 years | 6.4 | ||||||
[52] | Abdullahi et al. 2012 | 2006–2009 | Kenya | 2840 children | Point | 3–59 months | 65.8 |
[51] | Tigoi et al. 2012 | 2006–2009 | Kenya | 1404 children, 1372 mothers, 221 fathers, and 1412 siblings | Average | Mean: 2.1 days. Mean age family members: NR | 63.2b |
[64] | Valles et al. 2006 | 2003 | Mozambique | 285 children | Point | <5 years | 87 |
[38] | Coles et al. 2008 | 2003–2005 | Nepal | 197 children | Point | 1–36 months | 78.7a |
[63] | Moyo et al. 2012 | 2010 | Tanzania | 300 children | Point | <5 years | 35 |
Immunocompromised population | |||||||
[117] | Rusen et al. 1997 | 1990 | Kenya | 26 children with HIV | Point | <5 years | 86 |
[58] | Abdullahi et al. 2012 | 2006–2008 | Kenya | 99 children with HIV | Point | 3–59 months | 76 (66–84) |
[41] | Anthony et al. 2012 | 2008 | Tanzania | 142 children with HIV | Point | 1–4 years | 88 |
5–9 years | 77 | ||||||
10–14 years | 76 | ||||||
[59] | Kateete et al. 2012 | 2001–2002 | Uganda | 81 children with homozygote sickle cell disease | Point | 8 months–6 years | 33 |
[40] | Blossom et al. 2006 | 2004–2005 | Uganda | 600 individuals with HIV | Point | Adults (mean age 38.15 years) | 18 |
Sick population | |||||||
[39] | Lloyd-Evans et al. 1996 | 1989–1991 | The Gambia | 1152 children: 1071 sick (clinical diagnosis of pneumonia, meningitis, septicemia, or other serious bacterial infection) and 81 with IPD | Point | <5 years | Sick: 85.1. IPD: 90.1 |
[38] | Coles et al. 2008 | 2003–2005 | Nepal | 197 children with ALRI | Point | 1–36 months | 80.2a |
Lower-middle income countries | |||||||
Healthy population | |||||||
[68] | Russell et al. 2006 | 2003–2004 | Fiji | 774 children | Point | 3–13 months | 44.3 |
[56] | Regev-Yochay et al. 2012 | 2009 | Gaza strip | 379 children | Point | 3 weeks–5.5 years | 50 |
379 parents | NR | 8 | |||||
[66] | Denno et al. 2002 | 1996 | Ghana | 311 children | Point | 6–12 months | 51.4 |
[118] | Donkor et al. 2010 | 2006–2007 | Ghana | 124 children | Point | <13 years | 15.3 |
[119] | Coles et al. 2001 | 1998–1999 | India | 225 infants | Point | 2 months | 54.2 |
4 months | 67.9 | ||||||
6 months | 69.8 | ||||||
[75] | Das et al. 2002 | 2000–2001 | India | 566 children | Point | 5–12 years | 29.1 |
[120] | Devi et al. 2012 | 2009–2010 | India | 811 children | Point | 0–14 years | 12.8 |
[67] | Rupa et al. 2012 | 2009–2010 | India | 210 children | Point | 0–1 years | Maximum: 46.3 |
[121] | Wattal et al. 2007 | NR | India | 200 children | Point | 3 months–3 years | 6.5 |
[69] | Soewignjo et al. 2001 | 1997 | Indonesia | 484 children | Point | 0–25 months | 48 (42–54)c |
[122] | Adetifa et al. 2012 | NR | Nigeria | 1005 individuals | Point | All ages | 52.5 (49.4–55.7) |
[36] | Vu et al. 2011 | 2007–2008 | Vietnam | 350 children | Point | <5 years | 50.3 |
[123] | Gill et al. 2008 | 2003–2005 | Zambia | 132 children born to HIV+ mothers and 128 children born to HIV− mothers | Average | 6 weeks | 25.8 |
Immunocompromised population | |||||||
[70] | Bhattacharya et al. 2012 | 2008–2009 | India | 148 children with HIV | Point | 1–16 years | 28 |
[71] | Mwenya et al. 2010 | 2002–2003 | Zambia | 439 children with HIV | Point | 6 months–14 years | 51 |
[124] | Gill et al. 2008 | 2003–2005 | Zambia | 132 women with HIV | Average | Mean: 25.9 years | 11.4 |
Sick population | |||||||
[62] | Mastro et al. 1993 | 1989–1990 | Pakistan | 601 children with ARI | Point | Mean:14.5 months | 64.4 |
[60] | Lankinen et al. 1994 | 1984 | The Philippines | 318 children with ALRI | Point | <5 years | 51 |
[61] | Lupisan et al. 2000 | 1994 | The Philippines | 956 children with severe pneumonia, suspected meningitis, or clinical suspicion of sepsis. | Point | 0–59 months | 27.9 |
[36] | Vu et al. 2011 | 2007–2008 | Vietnam | 274 children with radiologically confirmed pneumonia | Point | <5 years | 38.7 |
276 children with other LRTI | 43.3 |
ALRI, acute lower respiratory infection; ARI, acute respiratory infection; HIV, human immunodeficiency virus; IPD, invasive pneumococcal disease; LRTI, lower respiratory tract infection; NR, not reported.
Carriage rate is from the control group.
Overall carriage rate. Children, mothers, fathers, and siblings combined.
Age- and population-weighted carriage rate, adjusted for design effect.